Clinical trial
A Pharmacokinetic Evaluation Study in Healthy Volunteers
NCT00210054 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00210054 |
|---|---|
| Title | A Pharmacokinetic Evaluation Study in Healthy Volunteers |
| Official title | Pilot Single-Dose Intravenous Pharmacokinetic Evaluation of INS37217 Solution in Healthy Volunteers |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | denufosol tetrasodium (INS37217) |
| Enrollment | 4 |
| Start date | Nov 1, 2002 |
| Primary completion | Dec 1, 2002 |
| Completion | Dec 1, 2002 |
| First posted | Sep 21, 2005 |
| Last update posted | Oct 12, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: